HIV prevention: New look at PrEP study points to efficacy for transgender women

In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, researchers have identified strong evidence of efficacy for transgender women when PrEP, a two-drug antiretroviral used to prevent HIV, is used consistently.